Osmotica Pharmaceuticals (OSMT) in Focus: Stock Moves 6.7% Higher

Published on 25 Nov 2020 on Zacks via Yahoo Finance

Osmotica Pharmaceuticals (OSMT) in Focus: Stock Moves 6.7% Higher

Osmotica Pharmaceuticals plc OSMT was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $5.09 –$6.99 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Osmotica Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Read the rest of the article

Want to become a better investor?

Start tracking your investments with Statfolio

News

Osmotica Pharmaceuticals (OSMT) in Focus: Stock Moves 6.7% Higher

Want to become a better investor?

54 Biggest Movers From Thursday

18 Stocks Moving in Thursday's Pre-Market Session

79% of Growth to Originate from APAC for Copper Market | Evolving Opportunities with Aditya Birla...

Executive VP & COO James Schaub Just Bought 30% More Shares In Osmotica Pharmaceuticals plc...

Loss-Making Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Expected To Breakeven In The Medium-Term

What Kind Of Shareholders Hold The Majority In Osmotica Pharmaceuticals plc's (NASDAQ:OSMT) Shares?

Osmotica Stock Surges On $170M Divestiture Deal With Alora Pharmaceuticals

Is Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Popular Amongst Institutions?

Osmotica Pharmaceuticals (OSMT) in Focus: Stock Moves 6.7% Higher

Did Osmotica Pharmaceuticals' (NASDAQ:OSMT) Share Price Deserve to Gain 72%?